QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study 期刊论文 2019 作者:  Song Yuqin;  Gao Quanli;  Zhang Huilai;  Fan Lei;  Zhou Jianfeng 收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03 Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文 2019, 卷号: 110, 期号: 4, 页码: 1503-1503 作者:  Hu, Shaoxuan;  Song, Yuqin;  Sun, Xiuhua;  Su, Liping;  Zhang, Wei 收藏  |  浏览/下载：65/0  |  提交时间：2020/01/03 Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study 期刊论文 2019, 卷号: 14, 期号: 2, 页码: 149-158 作者:  Hong, Xiaonan;  Song, Yuqin;  Huang, Huiqiang;  Bai, Bing;  Zhang, Huilai 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure 期刊论文 2018, 卷号: 109, 期号: 12, 页码: 3943-3952 作者:  Hu, Shaoxuan;  Song, Yuqin;  Sun, Xiuhua;  Su, Liping;  Zhang, Wei 收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03 breast  diffuse large B-cell lymphoma  radiotherapy  relapse  rituximab   Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 期刊论文 2018, 卷号: 132 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文 2018, 卷号: 132 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文 BLOOD, 2018-11-29 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文 BLOOD, 2018-11-29 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文 2017, 卷号: 10, 期号: 1, 页码: 69 作者:  Shi, Yuankai;  Jia, Bo;  Xu, Wei;  Li, Wenyu;  Liu, Ting 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/04 Chidamide  Peripheral T cell lymphoma  Treatment  Chemotherapy   Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS) 会议论文 BLOOD, 2016-12-02 作者:  Hu, Shaoxuan;  Song, Yuqin;  Li, Yufu;  Sun, Xiuhua;  Su, Liping 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04